期刊文献+

肝胃百合汤联合雷贝拉唑治疗慢性胃炎42例 被引量:6

Treating 42 Cases of Chronic Gastritis by Liver-stomach Lilii Decoction and Rabeprazole
下载PDF
导出
摘要 目的:观察肝胃百合汤联合雷贝拉唑治疗慢性胃炎的临床疗效。方法:将84例患者随机分为观察组和对照组,每组42例。2组均口服雷贝拉唑治疗,观察组在此基础上服用肝胃百合汤,比较2组临床疗效、复发率及治疗前后临床症状评分的变化情况。结果:总有效率观察组为92.86%,对照组为73.81%,2组比较差异有统计学意义(P<0.05)。腹痛、腹胀、口苦、恶心等临床症状评分治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较差异也有统计学意义(P<0.05)。复发率观察组为7.14%,对照组为16.67%,2组比较差异有统计学意义(P<0.05)。结论:肝胃百合汤联合雷贝拉唑治疗慢性胃炎临床效果较好,且可降低复发率。 Objective: To observe curative effects of liver-stomach lilii decoction and rabeprazole in treatingchronic gastritis (CG). Methods: All 84 patients were randomized into the observation group and the control group,42 cases each group. Both groups took Rabeprazole, the observation group took liver-stomach lilii decoctionsimultaneously, the changes of clinical symptoms scores, the recurrence rate and clinical effects of the patients werecompared between both groups. Results: Total effective rate of the observation group was 92.86%, higher than73.81% of the control group, and there was a significant difference(P〈0.05). The difference had statistical meaningin the comparisons of the scores of clinical symptoms including abdominal pain, abdominal distension, bitter mouth,nausea and others(P〈0.05); the difference was statistically significant in the comparisons between both groups after treating(P〈0.05). The recurrence rate of the observation group was 7.14%, lower than 16.67% of the controlgroup, and there was a significant difference(P〈0.05). Conclusion:Liver-stomach lilii decoction and rabeprazole intreating CG could obtain better effects and reduce the recurrence rate.
作者 穆雷霞 王磊 MU Leixia;WANG Lei(Department of Gastroenterology,Qingyang Municipality People忆s Hospital,Qingyang 745000,China)
出处 《西部中医药》 2018年第10期88-90,共3页 Western Journal of Traditional Chinese Medicine
关键词 胃炎 慢性 肝胃百合汤 雷贝拉唑 gastritis chronic liver-stomach lilii decoction Rabeprazole
  • 相关文献

参考文献6

二级参考文献78

  • 1王长洪,王艳红,周莹,樊新亚,高学武,陈山泉.中药对胃粘膜合成前列腺素的临床及实验研究[J].中国中西医结合杂志,1994,14(9):528-530. 被引量:33
  • 2中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:834
  • 3陆再英,钟南山.内科学(第7版)[M].北京:人民卫生出版社,2008,726-728.
  • 4Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with on-steroidal anti-inflammatory drug use[ J]. Am J Gastroentero1,2005,100( 8 ) : 1685 - 1689.
  • 5Fisher M, Knappertz V. The dose of aspirin for the prevention of car- diovascular and eerebmvascular events[ J]. Curt Med Res Opin,2006, 22(7) :1239 - 1248.
  • 6刘婧,李兆申,许国铭.奥美拉唑、铝碳酸镁和米索前列醇对大鼠急性胃粘膜损伤保护作用及机制[J].中国临床中药国理药学与治疗学,2006,11(9):1056-1059.
  • 7BE ancon M , Simon A, Sachs G,et al. Sites of reaction of the gastric H-K-ATPase with extracytoplmic thio reagents[ J]. JBiol Chem, 1997, 272(136) :22438 -22446.
  • 8Hmnphries TJ, Merrltt GJI Review article: drug intiraetion with a- gent-sused to treat aeidrelalel diseases [ J ]. Aliment Phannaeol Ther, 1999,13(3) :18 -26.
  • 9HarumaK, hoM. Review article: clinical sigificanee of mucosal- pro- tective agents: acid, inflammation, carcinogenesis and rebamipide [ J ]. Aliment Pharmaeol Ther,2003,17 ( 1 ) : 153 - 159.
  • 10Naito Y, Kajikawa H, Mizushima K, et al. Rebamipide, a gastro-protec-tive drug,inhibits indomethacin-indueed apoptosis in cultured rat gas- tric mueosal cells : association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression [ J]. Dig Dis Sci ,2005,50 (1) :104-112.

共引文献148

同被引文献54

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部